Bullish case
$155 to $165
More likely if Japan sales recover, U.S. premiums keep growing, yen pressure fades, investment income stays healthy, buybacks reduce share count, and the market pays about 15x forward earnings.
Aflac Incorporated research snapshot
AFL AI stock analysis currently reads Aflac Incorporated as a high-quality supplemental insurance franchise with strong Japan and U.S. positions, conservative underwriting culture, steady capital returns, yen sensitivity, and valuation that already prices in a meaningful amount of stability. At the July 8, 2026 data cutoff, AFL traded near $121.49 with an independently verified market capitalization of about $61.84 billion. This page uses scenarios, technical levels, and source-backed facts. It is informational research, not investment advice.
Current price
$121.49
Market cap
$61.84 billion
AI score
72 / 100
Rating
Durable insurer, valuation discipline needed
Trend status
Constructive long-term trend with near-term resistance
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Aflac sells supplemental health and life insurance mainly through Aflac Japan and Aflac U.S., with cash generation supported by persistency, scale, and investment income. | High |
| Moat | The moat comes from trusted brand recognition, distribution reach, Japan market leadership in cancer and medical insurance, regulatory know-how, and decades of policyholder relationships. | Medium-high |
| Management | Daniel P. Amos has led the company for decades. The key test is whether management can keep capital returns disciplined while adapting Japan and U.S. sales channels. | Medium-high |
| Financial trend | FY2025 revenue declined 9.3% to $17.164 billion, but TTM revenue recovered to about $18.112 billion and Q1 2026 adjusted EPS rose 5.4% to $1.75. | High |
| Valuation | At $121.49 and $8.81 TTM EPS, AFL traded near 13.8x earnings, 2.1x book value, and a 2.0% dividend yield. | High |
| Technical trend | Investing.com showed a daily strong buy setup, with price above the 50-day and 200-day moving averages but close to a Fibonacci pivot area near $121.68. | Medium |
| Risk level | Main risks are currency translation, Japanese premium pressure, lower persistency, reserve changes, investment losses, interest-rate volatility, and slow U.S. growth. | Medium-high |
| AI confidence | High for descriptive research and calculations. Lower for exact price outcomes because insurer earnings can move with rates, currency, claims, and accounting marks. | High data confidence |
| Investment certainty | Medium certainty. AFL looks like a resilient business, but a buy decision depends on price, currency view, and confidence in mid single digit earnings growth. | Medium |
AFL AI stock forecast
The AFL AI stock forecast uses scenario math around the $121.49 quote, $8.81 TTM EPS, and current book value. The audited three-year framework produced a bearish area near $80, a base area near $129, and a bullish area near $162 before dividends.
$155 to $165
More likely if Japan sales recover, U.S. premiums keep growing, yen pressure fades, investment income stays healthy, buybacks reduce share count, and the market pays about 15x forward earnings.
$125 to $132
More likely if EPS compounds near 4% annually, persistency remains steady, book value grows modestly, and investors value AFL around a 13x earnings multiple.
$78 to $84
More likely if yen weakness, reserve changes, claims pressure, investment losses, or weaker policy sales reduce earnings and compress the multiple toward 10x.
AFL AI technical analysis
AFL AI technical analysis is constructive as of the July 8, 2026 cutoff. Investing.com reported a daily strong buy signal, a 14-day RSI of 58.295, a 50-day moving average of $119.71, and a 200-day moving average of $117.02.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $121.49 | StockAnalysis close on July 7, 2026, used for market cap and valuation math at the July 8, 2026 cutoff. |
| Near support | $119.70 to $121.00 | The 50-day moving average near $119.71 and the recent trading area create the first support zone to watch. |
| Near resistance | $121.68 to $122.25 | Investing.com listed a Fibonacci pivot near $121.68, while Robinhood showed July 7 intraday high near $122.25. |
| 50-day moving average | $119.71 | Price remained above this level, supporting the intermediate trend. |
| 200-day moving average | $117.02 | Price remained above the 200-day average, keeping the long-term trend constructive. |
| Momentum | 14-day RSI 58.295 | RSI was positive but not extreme, so momentum was constructive without a clear overbought warning. |
| Volume | About 2.43 million average daily shares | Robinhood listed average daily volume near 2.43 million shares, enough liquidity for most large-cap monitoring frameworks. |
| Volatility | Moderate insurer volatility | Expect larger moves around earnings, yen moves, rate changes, reserve updates, and capital return announcements. |
| Invalidation | Close below $119.70, then $117.00 | A close below the 50-day average would weaken the short-term setup. A break below the 200-day average would be a more serious trend warning. |
AFL AI trading strategy
The AFL AI trading strategy is a rules-based research framework for a mature insurer with visible capital returns and currency sensitivity. It is not personal advice and should be paired with live quotes, filings, position sizing, and risk controls.
Watch for AFL to hold above the 50-day moving average and clear the $121.68 to $122.25 resistance area with volume confirmation.
A close below $119.70 or a failed breakout after earnings should invalidate the short-term setup.
If AFL pulls back toward the 200-day moving average without a new underwriting, reserve, or currency shock, compare the price reaction with book value, ROE, and buyback activity.
Do not average down without a defined loss limit because insurance stocks can reprice quickly when accounting marks or claim trends change.
Track Japan sales, U.S. net earned premiums, persistency, adjusted ROE, book value per share, yen translation, debt, buybacks, and dividend growth.
Reduce confidence if EPS growth relies mainly on valuation expansion rather than underwriting profit, investment income, book-value growth, and lower share count.
Investment research summary
Aflac converts trusted distribution, supplemental insurance products, policy persistency, and invested float into recurring premiums, investment income, and shareholder returns.
The moat is strongest in brand, Japan market presence, regulatory experience, distribution, and long policyholder relationships. It narrows if new channels, pricing pressure, or better digital competitors reduce acquisition strength.
The thesis fails if Japan premiums decline faster than expected, yen weakness persists, claims or reserves deteriorate, investment marks damage book value, or buybacks occur at poor prices.
Daniel Amos gives Aflac rare leadership continuity. The risk is key-person dependence and the need to modernize sales channels without weakening the conservative culture that built the franchise.
Supplemental insurance benefits from healthcare cost gaps, aging populations, and consumer need for cash benefits, but growth is mature and sensitive to employment, regulation, and channel productivity.
AFL is not priced as a troubled insurer. Margin of safety depends on steady ROE, disciplined buybacks, dividend durability, and whether investors are comfortable paying about 13.8x TTM earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| AFL price | $121.49 close on July 7, 2026 | StockAnalysis quote snapshot | July 8, 2026 |
| Market capitalization | $61.84 billion, verified as $121.49 x 508.98 million shares | financial_rigor.py market cap verification | July 8, 2026 |
| FY2025 revenue | $17.164 billion | Aflac 2025 Form 10-K, StockAnalysis, and Macrotrends | July 8, 2026 |
| FY2025 net earnings | $3.646 billion | Aflac 2025 Form 10-K and StockAnalysis cross-check | July 8, 2026 |
| Q1 2026 adjusted EPS | $1.75, up 5.4% year over year | Aflac Q1 2026 earnings release | July 8, 2026 |
| Aflac Japan Q1 2026 adjusted revenue and margin | $2.172 billion adjusted revenue, 35.0% pretax adjusted margin | Aflac Q1 2026 earnings release | July 8, 2026 |
| Aflac U.S. Q1 2026 net earned premiums | $1.555 billion, up 3.5% year over year | Aflac Q1 2026 earnings release | July 8, 2026 |
| Cash and debt | $8.27 billion cash and $14.46 billion total debt | StockAnalysis statistics and Yahoo Finance cross-check | July 8, 2026 |
| Book value per share | $58.69 at March 31, 2026 | Aflac Q1 2026 earnings release | July 8, 2026 |
| Technical snapshot | Strong buy daily signal, RSI 58.295, 50-day MA $119.71, 200-day MA $117.02 | Investing.com technical analysis | July 8, 2026 |
This AFL AI stock analysis is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of July 8, 2026 and may be wrong if Aflac fundamentals, interest rates, currency, claims, regulation, or market valuation change.